Cell Therapy: A Novel Treatment Approach for Bronchopulmonary Dysplasia
- 1 October 2012
- journal article
- review article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 130 (4) , 727-737
Abstract
Bronchopulmonary dysplasia (BPD) is a major cause of substantial lifelong morbidity in preterm infants. Despite a better understanding of the pathophysiology of BPD and significant research effort into its management, there remains today no effective treatment. Cell-based therapy is a novel approach that offers much promise in the prevention and treatment of BPD. Recent research supports a therapeutic role for cell transplantation in the management of a variety of acute and chronic adult and childhood lung diseases, with potential of such therapy to reduce inflammation and prevent acute lung injury. However, considerable uncertainties remain regarding cell therapies before they can be established as safe and effective clinical treatments for BPD. This review summarizes the current literature investigating cell therapies in lung disease, with particular focus on the various types of cells available and their specific properties in the context of a future therapy for BPD.Keywords
This publication has 113 references indexed in Scilit:
- Stem Cell Based Cancer Gene TherapyMolecular Pharmaceutics, 2011
- RETRACTED: Evidence for Human Lung Stem CellsNew England Journal of Medicine, 2011
- The Pathology of Bleomycin-Induced Fibrosis Is Associated with Loss of Resident Lung Mesenchymal Stem Cells That Regulate Effector T-cell ProliferationStem Cells, 2011
- Transplantation of Human Embryonic Stem Cell–Derived Alveolar Epithelial Type II Cells Abrogates Acute Lung Injury in MiceMolecular Therapy, 2010
- Stem cells are dispensable for lung homeostasis but restore airways after injuryProceedings of the National Academy of Sciences, 2009
- Murine bone marrow–derived mesenchymal stem cells as vehicles for interleukin‐12 gene delivery into Ewing sarcoma tumorsCancer, 2008
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences, 2007
- Isolation of amniotic stem cell lines with potential for therapyNature Biotechnology, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem CellCell, 2001